メイン州における卵巣がんの臨床試験
メイン州内の拠点で、卵巣がんに関する9件の研究が参加者を募集しています。
メイン州内の都市
公式研究テキスト（英語）
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Harold Alfond Center for Cancer Care, Augusta
- Lafayette Family Cancer Center-EMMC, Brewer
- MaineHealth Maine Medical Center- Scarborough, Scarborough
- 他1件
被験者募集中第2相
全年齢 · 全性別 · 2026/10/02更新 · NCT05564377A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
- Maine Medical Center - Scarborough Campus /ID# 277205, Scarborough
被験者募集中第2相
18歳以上 · 女性 · 2026/09/22更新 · NCT07059845A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- Maine Medical Center - Scarborough Campus, Scarborough
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07213804A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
- Maine Medical Center Research Institute-MaineHealth/Maine Medical Partners - GynOnc ( Site 0060), Scarborough
被験者募集中第3相
18歳以上 · 女性 · 2026/09/17更新 · NCT07318558Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- Maine Center For Cancer Medicine, Scarborough
被験者募集中第3相
18歳以上 · 女性 · 2026/09/15更新 · NCT07214779A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
- Maine Medical Center Research Institute-MaineHealth/Maine Medical Partners - GynOnc ( Site 0008), Scarborough
被験者募集中第3相
18歳以上 · 女性 · 2026/09/03更新 · NCT06824467A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- MaineHealth Maine Medical Center - Portland, Portland
- MaineHealth Maine Medical Center- Scarborough, Scarborough
被験者募集中
35歳〜50歳 · 女性 · 2026/08/07更新 · NCT04251052Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- MaineHealth Maine Medical Center- Scarborough, Scarborough
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/07更新 · NCT06580314SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Scarborough
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。